Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: A systematic literature review

American Journal of the Medical Sciences

Volumn 334, Issue 4, 2007, Pages 248-254

  Gossec, Laure ^a,b   Tubach, Florence ^b,c   Dougados, Maxime ^a   Ravaud, Philippe ^b,c  

^a Paris 5 University ^*  (France)

^b INSERM   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Adherence; Compliance; Quality of trials; Randomized controlled trials

Indexed keywords

ASTHMA; CHRONIC DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG SELF ADMINISTRATION; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFORMATION RETRIEVAL; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATOID ARTHRITIS; STANDARD; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; COMPARATIVE STUDY; METHODOLOGY; PILOT STUDY; TREATMENT REFUSAL;

ARTHRITIS, RHEUMATOID; ASTHMA; DIABETES MELLITUS; HIV INFECTIONS; HUMANS; HYPERTENSION; OSTEOPOROSIS; PATIENT COMPLIANCE; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT REFUSAL;

EID: 38449115203     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318068dde8     Document Type: Article

References (29)

1. R.B. Haynes D.W. Taylor D.L. Sackett Compliance in Healthcare. 1979 The John Hopkins University Press Baltimore
2. Cramer J. Rosenheck R. Kirk G. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes Value Health 6 2003 566 573
3. Haynes R.B. Sackett D.L. Gibson E.S. Improvement of medication compliance in uncontrolled hypertension Lancet 1 1976 1265 1268
4. Blackwell B. From compliance to alliance: a quarter century of research Neth J Med 48 1996 140 149
5. Greenberg R.N. Overview of patient compliance with medication dosing: a literature review Clin Ther 6 1984 592 599
6. Christensen D.B. Drug-taking compliance: a review and synthesis Health Serv Res 198 1978 171 187
7. Cramer J.A. Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence Am J Managed Care 4 1998 1563 1568
8. Haynes R.B. Dantes R. Patient compliance and the conduct and interpretation of clinical trials Control Clin Trials 8 1987 12 19
9. J.A. Cramer B. Spilker Patient compliance in medical practice and clinical trials. 1991 Raven Press New York
10. Moher D. Schulz K.F. Altman D. CONSORT Group (Consolidated Standards of Reporting Trials) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials JAMA 285 2001 1987 1991
11. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. Structure and content of clinical study reports, E3. Available at http://www.ich.org
12. Nichol M.B. Venturini F. Sung J.C. A critical evaluation of the methodology of the literature on medication compliance Ann Pharmacother 33 1999 531 540
13. Claxton A.J. Cramer J. Pierce C. A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 2001 1296 1310
14. Olivieri N.F. Matsui D. Hermann C. Compliance assessed by the Medication Event Monitoring System Arch Dis Child 66 1991 1399 1402
15. Lang J.M. Buring J.E. Rosner B. Estimating the effect of the run-in on the power of the Physicians’ Health Study Stat Med 10 1991 1585 1593
16. van Rooyen S. Godlee F. Evans S. Effect of blinding and unmasking on the quality of peer review: a randomized trial JAMA 280 1998 234 237
17. Justice A.C. Berlin J.A. Fletcher S.W. Do readers and peer reviewers agree on manuscript quality? JAMA 272 1994 117 119
18. Jadad A.R. Moore R.A. Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
19. Verhagen A.P. de Vet H.C. de Bie R.A. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus J Clin Epidemiol 51 1998 1235 1241
20. Verhagen A.P. de Vet H.C. Vermeer F. The influence of methodologic quality on the conclusion of a landmark meta-analysis on thrombolytic therapy Int J Technol Assess Health Care 18 2002 11 23
21. Hill C.L.L.M. Felson D.T. Discrepancy between published report and actual conduct of randomized clinical trials J Clin Epidemiol 55 2002 783 786
22. Maenpaa H. Manninen V. Heinonen O.P. Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial Eur Heart J 8 1987 39 43
23. Melkinow J. Kiefe C. Patient compliance and medical research: issues in methodology J Gen Intern Med 9 1994 96 105
24. Rudd P. Byyny R.L. Zachary V. The natural history of medication compliance in a drug trial: limitations of pill counts Clin Pharmacol Ther 46 1989 169 176
25. Caron H.S. Compliance: the case for objective measurement J Hypertens 3 suppl 1 1985 11 17
26. Mushlin A.I. Appel F.A. Diagnosing potential non-compliance: physician’s ability in a behavorial dimension of medical care Arch Intern Med 137 1977 318
27. Lindsey J.C. McGrath N.M. Interpreting treatment differences when patients drop out of a clinical trial AIDS Patient Care STDS 12 1998 275 285
28. Hogan J.W. Laird N.M. Intention-to-treat analyses for incomplete repeated measures data Biometrics 52 1996 1002 1017
29. Lee K.P. Schotland M. Bacchetti P. Association of journal quality indicators with methodological quality of clinical research articles JAMA 287 2002 2805 2808